Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06367387 · ClinicalTrials.gov registry record · Phase 4

Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment

A Phase 4 study of Chronic Pain and Opioid Use Disorder, sponsored by Erin Winstanley.

Active
Registry status
Phase 4
Development phase
268
Enrollment target
13
Study locations

NCT06367387 is a Phase 4 study of Chronic Pain and Opioid Use Disorder that is active but no longer recruiting, run by Erin Winstanley. The registered enrollment target is 268 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (65% lower). The trial reports 13 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06367387, a Phase 4 study of Chronic Pain and Opioid Use Disorder, is active but no longer recruiting, sponsored by Erin Winstanley.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
268 participants
Enrollment target
13
Study locations

Study Summary

This study seeks to improve the treatment of chronic pain in people who are taking buprenorphine (also known as Suboxone, Subutex, Zubsolv). The research study is testing two different interventions along with usual clinical care: 1. Pain Self-Management (PSM): an educational program in which individuals with chronic pain work with a trained pain coach and a pain peer to explore strategies to effectively manage the daily problems that arise from chronic pain. 2. Patient-Oriented Dosing (POD): an alternative dosing of buprenorphine which will be adjusted based on pain levels. The interventions will take place over a period of 12 weeks (3 months). Additionally, participants will complete surveys every 3 months for a period of 1 year (total of 5 survey visits). Participants will receive $50 compensation for each survey visit completed (up to $250 over one year) and can receive up to an additional $100 bonus compensation. There are risks associated with participating in the study, including breach of confidentiality, psychological distress caused by discussing difficult topics, and risks associated with the POD intervention.

Conditions Studied

Chronic Pain Opioid Use Disorder

Interventions

  • BEHAVIORAL Usual Care
  • DRUG Patient-Oriented Dosing (POD)
  • BEHAVIORAL Pain Self-Management (PSM)
  • DRUG Standard Buprenorphine Dosing Condition

Study Locations (13)

Oregon

  • Central City Concern (CCC) - Portland
  • Recovery Works Northwest (RWNW) - Portland
  • OHSU Harm Reduction Bridges to Care (HRBR) - Portland
  • OHSU Internal Medicine Clinic (IMC) - Portland

Pennsylvania

  • UPMC Latterman Family Health Center - McKeesport
  • UPMC St. Margaret Family Health Center - New Kensington
  • UPMC Magee-Womens Pregnancy and Women's Recovery Center (PWRC) - Pittsburgh
  • UPMC Internal Medicine Recovery Engagement Program (IM-REP) - Pittsburgh

Maryland

  • Alcohol and Drug Abuse Program (ADAP) - UM Addiction Treatment Center - Baltimore
  • MATClinics - Dundalk
  • Wells House - Hagerstown

West Virginia

  • WVU Crisis Support & Recovery Center - Martinsburg
  • WVU Chestnut Ridge Comprehensive Addiction Treatment Program (COAT) - Morgantown

Trial Details

FieldValue
Enrollment Target 268 participants
Start Date 2024-05-28
Est. Completion 2026-10-31
Phase Phase 4

Sponsor

Erin Winstanley

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06367387

The ClinicalTrials.gov registry entry for NCT06367387 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (65% lower). The listed sponsor is Erin Winstanley, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 4 interventions - of which Usual Care is the first listed.

NCT06367387 reports 13 study locations spanning 4 distinct geographic areas - top geographies include Oregon, Pennsylvania, Maryland.

Frequently Asked Questions

What is clinical trial NCT06367387 about?

NCT06367387 is a clinical study titled "Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment". This study seeks to improve the treatment of chronic pain in people who are taking buprenorphine (also known as Suboxone, Subutex, Zubsolv). The research study is testing two different interventions along with usual clinical care: 1. Pain Self-Management (PSM): an educational program in which indi...

What is the current status of trial NCT06367387?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 268 participants. The study started on 2024-05-28. Estimated completion is 2026-10-31.

What conditions does trial NCT06367387 study?

This clinical trial studies the following conditions: Chronic Pain, Opioid Use Disorder.

What interventions are being tested in trial NCT06367387?

The interventions under investigation include: Usual Care (BEHAVIORAL), Patient-Oriented Dosing (POD) (DRUG), Pain Self-Management (PSM) (BEHAVIORAL), Standard Buprenorphine Dosing Condition (DRUG).

Who is sponsoring clinical trial NCT06367387?

This trial is sponsored by Erin Winstanley, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06367387 being conducted?

This trial has 13 study locations across Maryland, Oregon, Pennsylvania, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Pain

All registered trials for this condition

Opioid Use Disorder

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.